Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about T CELL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
T CELL is a concept in neurodegeneration research. Key relationships include: co discussed, activates, associated with. Associated with ALZHEIMER'S DISEASE, CANCER, ENCEPHALITIS. Connected to 200 entities in the SciDEX knowledge graph.
| Name | T CELL |
| Related Diseases | NEURODEGENERATION, ALZHEIMER'S DISEASE, TUMOR |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
T_CELL["T CELL"]
COMPLEMENT["COMPLEMENT"] -->|"expressed in"| T_CELL
HSPG2["HSPG2"] -->|"expressed in"| T_CELL
CANCER["CANCER"] -->|"expressed in"| T_CELL
TCR["TCR"] -->|"expressed in"| T_CELL
CD40["CD40"] -->|"expressed in"| T_CELL
AQP4["AQP4"] -->|"expressed in"| T_CELL
HSPA1A["HSPA1A"] -->|"expressed in"| T_CELL
APOPTOSIS["APOPTOSIS"] -->|"expressed in"| T_CELL
NEURODEGENERATION["NEURODEGENERATION"] -->|"expressed in"| T_CELL
HSP70["HSP70"] -->|"expressed in"| T_CELL| Target | Relation | Type | Str |
|---|---|---|---|
| TUMOR | treats | disease | 0.65 |
| TUMOR | causes | disease | 0.65 |
| TUMOR | interacts_with | disease | 0.65 |
| T CELLS | accumulates_in | cell_type | 0.65 |
| T CELLS | reduces | cell_type | 0.65 |
| TUMOR | increases | disease | 0.65 |
| T CELLS | mediates | cell_type | 0.65 |
| T CELLS | transports | cell_type | 0.65 |
| T CELLS | increases | cell_type | 0.65 |
| TUMOR | protects_against | disease | 0.65 |
| TAU | activates | gene | 0.65 |
| TAU | phosphorylates | gene | 0.65 |
| TAU | interacts_with | gene | 0.65 |
| TAU | expressed_in | gene | 0.65 |
| UBIQUITIN | inhibits | gene | 0.65 |
| TNF | mediates | gene | 0.65 |
| T CELLS | expressed_in | cell_type | 0.60 |
| T CELLS | inhibits | cell_type | 0.60 |
| TUMOR | transports | disease | 0.60 |
| T CELLS | contributes_to | cell_type | 0.60 |
| TUMOR | contributes_to | disease | 0.60 |
| T CELLS | regulates | cell_type | 0.60 |
| T CELLS | interacts_with | cell_type | 0.60 |
| T CELLS | activates | cell_type | 0.60 |
| T CELLS | promotes | cell_type | 0.60 |
| TNF | causes | gene | 0.60 |
| TUMOR | activates | disease | 0.60 |
| T CELLS | protects_against | cell_type | 0.60 |
| T CELLS | treats | cell_type | 0.60 |
| TUMOR | inhibits | disease | 0.60 |
| T CELLS | associated_with | cell_type | 0.60 |
| T CELLS | stabilizes | cell_type | 0.60 |
| T CELLS | targets | cell_type | 0.60 |
| T CELLS | impairs | cell_type | 0.60 |
| TUMOR | regulates | disease | 0.60 |
| TNF | activates | gene | 0.60 |
| T CELLS | causes | cell_type | 0.60 |
| TUMOR | targets | disease | 0.60 |
| TBI | protects_against | disease | 0.60 |
| TUMOR | associated_with | disease | 0.60 |
| TUMOR | promotes | disease | 0.60 |
| T CELLS | co_discussed | entity | 0.50 |
| TBI | co_discussed | entity | 0.50 |
| TNF | co_discussed | entity | 0.50 |
| TREM2 | co_discussed | entity | 0.50 |
| ULK1 | co_discussed | entity | 0.50 |
| NEUROINFLAMMATION | activates | process | 0.50 |
| METFORMIN | inhibits | drug | 0.50 |
| CANCER | regulates | disease | 0.50 |
| INFLAMMATION | activates | process | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARKINSON'S DISEASE | associated_with | disease | 0.90 |
| TET2 | regulates | entity | 0.90 |
| NEURODEGENERATION | associated_with | disease | 0.82 |
| SLC16A1 | expressed_in | entity | 0.80 |
| MICROGLIA | associated_with | cell_type | 0.74 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.74 |
| TNF | activates | gene | 0.66 |
| CSF1R | inhibits | gene | 0.65 |
| NOTCH | causes | gene | 0.65 |
| CANCER | treats | disease | 0.65 |
| CANCER | targets | disease | 0.65 |
| NK CELL | activates | cell_type | 0.65 |
| MICROGLIA | accumulates_in | cell_type | 0.65 |
| SPINAL CORD | activates | brain_region | 0.65 |
| ENDOTHELIAL | contributes_to | cell_type | 0.65 |
| STING | inhibits | gene | 0.65 |
| NEUTROPHIL | increases | cell_type | 0.65 |
| ASTROCYTE | interacts_with | cell_type | 0.65 |
| ASTROCYTES | interacts_with | cell_type | 0.65 |
| NEURODEGENERATION | treats | disease | 0.65 |
| AKT | activates | gene | 0.65 |
| MTOR | activates | gene | 0.65 |
| PI3K | causes | gene | 0.65 |
| NEURON | activates | cell_type | 0.65 |
| ALZHEIMER | causes | disease | 0.65 |
| ALZHEIMER'S | causes | disease | 0.65 |
| ALZHEIMER'S DISEASE | causes | disease | 0.65 |
| IL-6 | transports | gene | 0.65 |
| MICROGLIA | transports | cell_type | 0.65 |
| CANCER | contributes_to | disease | 0.65 |
| NEURON | promotes | cell_type | 0.65 |
| NEURODEGENERATION | accumulates_in | disease | 0.65 |
| STING | targets | gene | 0.65 |
| MTOR | regulates | gene | 0.65 |
| MTOR | inhibits | gene | 0.65 |
| MYC | inhibits | gene | 0.65 |
| MTOR | reduces | gene | 0.65 |
| FOXP3 | regulates | gene | 0.65 |
| GLIOMA | expressed_in | disease | 0.65 |
| P53 | activates | gene | 0.65 |
| ISCHEMIA | inhibits | disease | 0.65 |
| OCLN | inhibits | gene | 0.65 |
| P62 | degrades | gene | 0.65 |
| AKT | regulates | gene | 0.65 |
| METFORMIN | regulates | drug | 0.65 |
| STING | phosphorylates | gene | 0.65 |
| PARKIN | targets | gene | 0.65 |
| PARKINSON | targets | disease | 0.65 |
| PARKINSON'S DISEASE | targets | disease | 0.65 |
| RAPAMYCIN | treats | drug | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Senescent Cell ASM-Complement Cascade Intervention | 0.552 | neurodegeneration | Lipid raft composition changes in synapt |
| Senescent Cell Mitochondrial DNA Release | 0.545 | neurodegeneration | Senolytic therapy for age-related neurod |
Scientific analyses that reference this entity
neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.514
neurodegeneration | 2026-04-11 | 0 hypotheses
cell biology | 2026-04-08 | 0 hypotheses
neurodegeneration | 2026-04-08 | 0 hypotheses
synaptic biology | 2026-04-08 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] | Yu CH, Davidson S, Harapas CR, Hilton JB | Cell | 2020 | 2 |
| Stimuli-responsive nanoplatforms for precision activation of the STING pathway i [PMID:41668757] | ["Bi D", "Yang X", "Wang Y", "Yong J", " | Frontiers in immunology | 2026 | 0 |
| Decoding senescent drivers in Alzheimer's disease: From bench to bedside. [PMID:41344577] | ["Zhou R", "Lin X", "Liao Z", "Lin J", " | Ageing research reviews | 2026 | 0 |
| Role of NEIL1 in genome maintenance. [PMID:40010204] | ["McCullough A", "Minko I", "Luzadder M" | DNA repair | 2025 | 0 |
| Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] | ["Ranjitha V", "Kumar A", "Kaalappa P"] | Pharmaceutical research | 2025 | 0 |
| Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven imm [PMID:40203808] | ["Lai P", "Liu L", "Bancaro N", "Troiani | Immunity | 2025 | 0 |
| Apheresis for senescence: Targeting the senescence-associated secretory phenotyp [PMID:40651559] | ["Akgun Y"] | Ageing research reviews | 2025 | 0 |
| Methodological influences on circulating cell-free-mitochondrial and nuclear DNA [PMID:40080226] | ["Daubermann C", "Herhaus B", "Neuberger | Molecular biology reports | 2025 | 0 |
| Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflamma [PMID:40902587] | ["Song Z", "Xie X", "Chen Y", "Zhang B", | Immunity | 2025 | 0 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment s [PMID:39825014] | Chestnykh D, Mühle C, Schumacher F, Kali | Mol Psychiatry | 2025 | 0 |
| Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and P [PMID:40166037] | Cruchaga C, Heo G, Thomas A, Wang E, Oh | Res Sq | 2025 | 0 |
| Reduction of sphingomyelinase activity associated with progranulin deficiency an [PMID:40633679] | Boyle NR, Fox SN, Tadepalli AS, Seyfried | Neurobiol Dis | 2025 | 0 |
| Antileukemic potential of methylated indolequinone MAC681 through immunogenic ne [PMID:38704604] | ["Orlikova-Boyer B", "Lorant A", "Gajula | Biomarker research | 2024 | 0 |
| Enhancing Radiofrequency Ablation for Hepatocellular Carcinoma: Nano-Epidrug Eff [PMID:39548919] | ["Li X", "Liu Y", "Ke J", "Wang Z", "Han | Advanced materials (Deerfield | 2024 | 0 |
| The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellul [PMID:39490400] | Zhang Y, Zou M, Wu H, Zhu J, Jin T | Neurobiology of disease | 2024 | 0 |
| mtDNA release promotes cGAS-STING activation and accelerated aging of postmitoti [PMID:39039044] | ["Li Y", "Cui J", "Liu L", "Hambright W" | Cell death & disease | 2024 | 0 |
| Senescent glia link mitochondrial dysfunction and lipid accumulation. [PMID:38839958] | ["Byrns C", "Perlegos A", "Miller K", "J | Nature | 2024 | 0 |
| Acid sphingomyelinase as a pathological and therapeutic target in neurological d [PMID:38337058] | Choi BJ, Park MH, Jin HK, Bae JS | Exp Mol Med | 2024 | 0 |
| EDIL3/Del-1 prevents aortic dissection through enhancing internalization and deg [PMID:38873925] | Yin Z, Zhang J, Zhao M, Liu J, Xu Y et a | Autophagy | 2024 | 0 |